Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
PFE News
Big Pharma may have gotten Trump off its back for now. But are drug prices coming down? For the past nine months, pharmaceutical companies have been paralyzed...
Pfizer (NYSE: PFE) made a deal with the White House to avoid paying tariffs on imported products. Where to invest $1,000 right now? Our analyst team just revea...
Pfizer, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Chris Schott from J.P. Morgan maintained a Hold rating on the stock...
Analyst ratings
60%
of 25 ratingsMore PFE News
Home Investing 3 Stocks Yielding 5% and More to Buy and Hold for the Next 5 Years Investing 3 Stocks Yielding 5% and More to Buy and Hold for the Next 5 Years...
These stocks can make your money work for you. I've become increasingly fonder of dividend stocks the older I've gotten. Part of the attraction is that I would...
In the past week, Pfizer reached a landmark agreement with the U.S. government to lower prices across a wide selection of prescription drugs, including aligning...
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump with th...
The shares of pharmaceutical giant Johnson & Johnson (JNJ) rose on Friday afternoon after the stock earned new price boosts from U.S. banking titans Wells Fargo...
Pfizer's deal with the Trump administration raised hopes that Eli Lilly would also avoid pharmaceutical tariffs. Shares in Eli Lilly (LLY 2.73%) had risen 13.2...
BofA analyst Tim Anderson raised the firm’s price target on Pfizer (PFE) to $30 from $28 and keeps a Neutral rating on the shares. While the timing of President...